The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Relation of Diabetes to Mild Cognitive Impairment
Abstract
BACKGROUND: Type 2 diabetes mellitus is an important risk factor for Alzheimer disease and is more prevalent in elderly minority persons compared with non-Hispanic white persons. OBJECTIVE: To determine whether diabetes is related to a higher risk of mild cognitive impairment (MCI), a transitional stage between normal cognition and Alzheimer disease, in a multiethnic cohort with a high prevalence of diabetes. DESIGN: Longitudinal cohort study. SETTING: Northern Manhattan in New York, NY. PARTICIPANTS: We studied persons without prevalent MCI or dementia at baseline and with at least 1 follow-up interval. Of 1772 participants with a complete neuropsychological evaluation, 339 (19.1%) were excluded because of prevalent dementia, 304 were excluded because of prevalent MCI (17.2%), and 211 were excluded because of loss to follow-up (11.9%), resulting in a final sample of 918 participants for longitudinal analyses. MAIN OUTCOME MEASURES: We related diabetes defined by self-report to incident all-cause MCI, amnestic MCI, and nonamnestic MCI. We conducted multivariate analyses with proportional hazards regression adjusting for age, sex, years of education, ethnic group, apolipoprotein E (APOE) epsilon4 allele, hypertension, low-density lipoprotein level, current smoking, heart disease, and stroke. RESULTS: A total of 334 persons had incident MCI, 160 (47.9%) had amnestic MCI, and 174 (52.1%) had nonamnestic MCI. Diabetes was related to a significantly higher risk of all-cause MCI and amnestic MCI after adjustment for all covariates. Diabetes was also related to a higher risk of nonamnestic MCI, but this association was appreciably attenuated after adjustment for socioeconomic variables and vascular risk factors. The risk of MCI attributable to diabetes was 8.8% for the whole sample and was higher for African American persons (8.4%) and Hispanic persons (11.0%) compared with non-Hispanic white persons (4.6%), reflecting the higher prevalence of diabetes in minority populations in the United States. CONCLUSION: Diabetes is related to a higher risk of amnestic MCI in a population with a high prevalence of this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with older adults without diabetes, those with the disease are at an increased risk of mild cognitive impairment (114).”
From Psychosocial care for people with diabetes: a position statement of the American Diabetes Association (2016) · cites this paper as [114]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. L., & Stadlan, E. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 9,882
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 9,034
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,269
Cited by
Sorted by citations
Items 101–200 of 591
Mediterranean Diet in Predementia and Dementia Syndromes
Solfrizzi, V., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P., D’Onofrio, G., Addante, F., Sancarlo, D., Cascavilla, L., Pilotto, A., et al. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391809 · Cited by 98
Regional Brain Gray Matter Changes in Patients with Type 2 Diabetes Mellitus
Roy, B., Ehlert, L., MULLUR, R. S., Freeby, M., Woo, M. A., Kumar, R., & CHOI, S. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-67022-5 · Cited by 92
Chow, Y. Y., Verdonschot, M., McEvoy, C. T., & Peeters, G. M. E. E. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109227 · Cited by 97
Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort
Bangen, K. J., Gu, Y., Gross, A. L., Schneider, B. C., Skinner, J. C., Benitez, A. M., Sachs, B. C., Shih, R. A., Sisco, S. M., Schupf, N., et al. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13441 · Cited by 92
Self-citationGórska-Ciebiada, M., Saryusz‐Wolska, M., Borkowska, A., Ciebiada, M., & Loba, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120433 · Cited by 87
An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia
Li, W., & Huang, E. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160114 · Cited by 91
Khater, M. S., & Abouelezz, N. F. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0021-9 · Cited by 85
Improved diabetes control in the elderly delays global cognitive decline
Luchsinger, J. A., Palmas, W., Teresi, J. A., Silver, S., Kong, J., Eimicke, J. P., Weinstock, R. S., & Shea, S. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0057-x · Cited by 87
Self-citationSong, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114647 · Cited by 88
Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study
Wright, C. B., DeRosa, J. T., Moon, M. P., Strobino, K., DeCarli, C. S., Cheung, Y. K., Assuras, S., Levin, B. E., Stern, Y., Sun, X., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201370 · Cited by 81
Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Panza, F., Frisardi, V., Seripa, D., Imbimbo, B. P., Sancarlo, D., D’Onofrio, G., Addante, F., Paris, F., Pilotto, A., & Solfrizzi, V. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391818 · Cited by 84
Ullah, R., Park, T. J., Huang, X., & Kim, M. O. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101451 · Cited by 78
Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 79
Diabetes and Cognitive Systems in Older Black and White Persons
Arvanitakis, Z., Bennett, D. A., Wilson, R. S., & Barnes, L. L. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bed5 · Cited by 76
Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment
Ebady, S. A., Arami, M. A., & Shafigh, M. H. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.020 · Cited by 75
Nunn, A. V. W., Bell, J. D., & Guy, G. W. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-16 · Cited by 77
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75
Guo, H., Tabara, Y., Igase, M., Yamamoto, M., Ochi, N., Kido, T., Uetani, E., Taguchi, K., Miki, T., & Kohara, K. (2009) · Hypertension Research · doi:10.1038/hr.2009.172 · Cited by 74
Shaikh, S., Rizvi, S. M. D., Shakil, S., Riyaz, S., Biswas, D., & Jahan, R. (2016) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1319 · Cited by 70
Toro, P., Schönknecht, P., & Schröder, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0981 · Cited by 71
Li, W., Sun, L., Li, G., & Xiao, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00180 · Cited by 74
Insulin: An Emerging Treatment for Alzheimer’s Disease Dementia?
Morris, J. K., & Burns, J. M. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0297-0 · Cited by 72
Relationships Between Diabetes and Cognitive Impairment
de la Monte, S. M. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.006 · Cited by 73
Quintessential Risk Factors: Their Role in Promoting Cognitive Dysfunction and Alzheimer’s Disease
Daulatzai, M. A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0854-6 · Cited by 70
Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
Michailidis, M., Tata, D. Α., Μoraitou, D., Kavvadas, D., Karachrysafi, S., Papamitsou, T., Vareltzis, P. K., & Papaliagkas, V. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094641 · Cited by 71
Retinal microvascular abnormalities and cognitive dysfunction: a systematic review
Ding, J., Patton, N., Deary, I. J., Strachan, M. W. J., Fowkes, F. G. R., Mitchell, R. J., & Price, J. F. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.141994 · Cited by 70
Bangen, K. J., Preis, S. R., Delano‐Wood, L., Wolf, P. A., Libon, D. J., Bondi, M. W., Au, R., DeCarli, C. S., & Brickman, A. M. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000215 · Cited by 68
Ramos‐Rodríguez, J. J., Jiménez-Palomares, M., Murillo-Carretero, M. I., Infante‐Garcia, C., Berrocoso, E., Pacho, F. H., Lechuga-Sancho, A. M., Cózar‐Castellano, I., & Garcı́a-Alloza, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.606 · Cited by 70
Acevedo, A., Krueger, K. R., Navarro, E., Ortiz, F., Manly, J. J., Padilla-Vélez, M. M., Weıntraub, S., López, O. L., & Mungas, D. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318193e376 · Cited by 69
Self-citationPeptides as Potential Therapeutics for Alzheimer’s Disease
Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69
Pardon, M., & Rattray, I. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.005 · Cited by 70
García‐Casares, N., Berthier, M. L., Jorge, R. E., Gonzalez-Alegre, P., Cardo, A. G., Rioja, J., Ación, L., Corbo, M. J. A., Nabrozidis, A., García-Arnés, J. A., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131736 · Cited by 69
Infante‐Garcia, C., Ramos‐Rodríguez, J. J., Galindo-Gonzalez, L., & Garcı́a-Alloza, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.12.001 · Cited by 67
Shin, A., Koo, B. K., Lee, J. Y., & Kang, E. H. (2024) · BMJ · doi:10.1136/bmj-2024-079475 · Cited by 69
Zhou, X., Zhang, J., Chen, Y., Ma, T., Wang, Y., Wang, J., & Zhang, Z. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132354 · Cited by 64
Cognitive dysfunction profile and arterial stiffness in type 2 diabetes
Mehrabian, S., Raycheva, M. R., Gateva, A., Todorova, G., Angelova, P., Traykova, M., Stankova, T., Kamenov, Z. A., & Traykov, L. D. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.046 · Cited by 69
Midlife stroke risk and cognitive decline: A 10‐year follow‐up of the Whitehall II cohort study
Kaffashian, S., Dugravot, A., Brunner, E. J., Sabia, S., Ankri, J., Mika Kivimaki, B., & Singh‐Manoux, A. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.07.001 · Cited by 64
Cukierman‐Yaffe, T., Bosch, J., Díaz, R., Dyal, L., Hâncu, N., Hildebrandt, P., Lanas, F. T., Lewis, B. S., Marre, M., Yale, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70062-2 · Cited by 64
Ramos‐Rodríguez, J. J., Spires‐Jones, T. L., Pooler, A. M., Lechuga-Sancho, A. M., Bacskai, B. J., & Garcı́a-Alloza, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9921-3 · Cited by 67
Hsiao, Y., Lin, C.-I., Liao, H., Chen, Y., & Lin, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120876 · Cited by 65
Lee, L. K., Shahar, S., Chin, A., Yusoff, N. A. M., Rajab, N., & Aziz, S. A. (2011) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2011.03.015 · Cited by 61
Evidence for altered insulin receptor signaling in Alzheimer's disease
Griffith, C. M., Eid, T., Rose, G. M., & Patrylo, P. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.008 · Cited by 64
Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice
Ramos‐Rodríguez, J. J., Ortiz-Barajas, O., Gamero-Carrasco, C., de la Rosa, P. R., Infante‐Garcia, C., Zopeque-Garcia, N., Lechuga-Sancho, A. M., & Garcı́a-Alloza, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.005 · Cited by 61
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes
Palleria, C., Leporini, C., Maida, F., Succurro, E., Sarro, G. D., Arturi, F., & Russo, E. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.07.002 · Cited by 61
Wang, D., Gao, K., Li, X., Shen, X., Zhang, X., Ma, C., Qin, C., & Zhang, L. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.013 · Cited by 59
The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics
Beeri, M. S., Ravona‐Springer, R., Moshier, E. L., Schmeidler, J., Godbold, J., Karpati, T., LeRoith, D., Koifman, K., Kravitz, E., Price, R., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.06.002 · Cited by 59
de la Monte, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_4 · Cited by 59
Zheng, T., Qin, L., Chen, B., Hu, X., Zhang, X., Liu, Y., Liu, H., Qin, S., Li, G., & Li, Q. (2016) · Diabetes Care · doi:10.2337/dc16-0316 · Cited by 57
de la Monte, S. M. (2012) · PubMed · Cited by 57
The characteristic of cognitive function in Type 2 diabetes mellitus
Gao, Y., Xiao, Y., Miao, R., Zhao, J., Zhang, W., Huang, G., & Ma, F. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.019 · Cited by 56
Therapeutic targets of brain insulin resistance in sporadic Alzheimer s disease
de la Monte, S. M. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e482 · Cited by 57
Cognitive function and retinal and ischemic brain changes
Haan, M. N., Espeland, M. A., Klein, R., Casanova, R., Gaussoin, S. A., Jackson, R. D., Millen, A. E., Resnick, S. M., Rossouw, J. E., Shumaker, S. A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31824d9655 · Cited by 56
Siddappaji, K. K., & Gopal, S. (2021) · AIMS neuroscience · doi:10.3934/neuroscience.2021020 · Cited by 58
Risk and protective factors for sporadic Alzheimer's disease.
Stožická, Z., Žilka, N., & Novák, M. (2007) · PubMed · Cited by 55
González, H. M., Tarraf, W., González, K. A., Fornage, M., Zeng, D., Gallo, L. C., Talavera, G. A., Daviglus, M. L., Lipton, R. B., Kaplan, R. C., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1676 · Cited by 54
Sheikh, M. H., Errede, M., d’Amati, A., Khan, N. Q., Fanti, S., Loiola, R. A., McArthur, S., Purvis, G. S. D., O’Riordan, C. E., Ferorelli, D., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101297r · Cited by 56
Epigenetic Mechanisms Linking Diabetes and Synaptic Impairments
Wang, J., Gong, B., Zhao, W., Tang, C. Y., Varghese, M., Nguyen, T., Bi, W., Bilski, A. E., Begum, S., Vempati, P., et al. (2013) · Diabetes · doi:10.2337/db13-1063 · Cited by 55
Johnson, L. A., Gamboa, A., Vintimilla, R., Cheatwood, A. J., Grant, A., Trivedi, A., Edwards, M., Hall, J. R., & O’Bryant, S. E. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142907 · Cited by 54
Trittschuh, E. H., Crane, P. K., Larson, E. B., Cholerton, B., McCormick, W. C., McCurry, S. M., Bowen, J. D., Baker, L. D., & Craft, S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101821 · Cited by 52
Current Epidemiological Approaches to the Metabolic-Cognitive Syndrome
Panza, F., Solfrizzi, V., Logroscino, G., Maggi, S., Santamato, A., Seripa, D., & Pilotto, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111496 · Cited by 52
Vascular Risk Factors and Cognitive Decline in a Population Sample
Ganguli, M., Fu, B., Snitz, B. E., Unverzagt, F. W., Loewenstein, D., Hughes, T. F., & Chang, C.-C. H. (2013) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000004 · Cited by 52
The association of diabetes and dementia and possible implications for nondiabetic populations
Ravona‐Springer, R., & Beeri, M. S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.152 · Cited by 55
Relation of Dysglycemia to Structural Brain Changes in a Multiethnic Elderly Cohort
Reitz, C., Guzman, V. A., Narkhede, A., DeCarli, C. S., Brickman, A. M., & Luchsinger, J. A. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14551 · Cited by 53
Self-citationCrosby‐Nwaobi, R., Sivaprasad, S., & Forbes, A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.11.010 · Cited by 52
Impaired Insulin Signaling and Mechanisms of Memory Loss
Bloemer, J., Bhattacharya, S., Amin, R., & Suppiramaniam, V. D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00013-2 · Cited by 52
Development of the T hai version of M ini‐ C og, a brief cognitive screening test
Trongsakul, S., Lambert, R., Clark, A., Wongpakaran, N., & Cross, J. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12318 · Cited by 57
Chen, R., Jiang, X., Zhao, X., Qin, Y., Gu, Z., Gu, P.-L., Zhou, B., Zhu, Z.-H., Xu, L., & Zou, Y.-F. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.04.009 · Cited by 51
High‐fat diet protects the blood–brain barrier in an Alzheimer's disease mouse model
Goldman, S. E., Goez, D., Last, D., Naor, S., Zaltsman, S. L., Sharvit‐Ginon, I., Atrakchi, D., Shemesh, C., Twitto‐Greenberg, R., Tsach, S., et al. (2018) · Aging Cell · doi:10.1111/acel.12818 · Cited by 52
Bruce, D. G., Davis, W. A., STARKSTEIN, S. E., & Davis, T. M. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132654 · Cited by 49
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
Suzanne, M. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/482 · Cited by 50
Christman, A. L., Vannorsdall, T. D., Pearlson, G. D., Hill‐Briggs, F., & Schretlen, D. J. (2009) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acp091 · Cited by 48
Jones, A., Kulozik, P., Ostertag, A., & Herzig, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0973 · Cited by 47
Gao, S., Chen, Y., Sang, F., Yang, Y., Xia, J., Li, X., Zhang, J., Chen, K., & Zhang, Z. (2019) · Diabetes · doi:10.2337/db19-0233 · Cited by 46
Type 2 Diabetes and Cognitive Compromise
Kravitz, E., Schmeidler, J., & Beeri, M. S. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.009 · Cited by 49
Psychiatric Disorders Presenting in the Elderly With Type 2 Diabetes Mellitus
Alagiakrishnan, K., & Sclater, A. L. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31823038db · Cited by 51
Hay, M., Barnes, C. A., Huentelman, M. J., Brinton, R. D., & Ryan, L. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01090-w · Cited by 51
Pelle, M. C., Zaffina, I., Giofrè, F., Pujia, R., & Arturi, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411301 · Cited by 50
Kalra, S. P. (2009) · Peptides · doi:10.1016/j.peptides.2009.07.021 · Cited by 45
Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55–64 Years
Luchsinger, J. A., Cabral, R., Eimicke, J. P., Manly, J. J., & Teresi, J. A. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000208 · Cited by 46
Self-citationGrigolon, R. B., Brietzke, E. M., Mansur, R. B., Idzikowski, M. A., Gerchman, F., Felice, F. G. D., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109720 · Cited by 47
Ribeiro, F. S., Teixeira-Santos, A. C., & Leist, A. K. (2021) · Aging & Mental Health · doi:10.1080/13607863.2021.2003297 · Cited by 45
Modeling Metabolic Syndrome and Its Association with Cognition: The Northern Manhattan Study
Levin, B., Llabre, M., Dong, C., Elkind, M., Stern, Y., Rundek, T., Sacco, R., & Wright, C. (2014) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617714000861 · Cited by 45
Kerola, T. V., Kettunen, R., & Nieminen, T. V. M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.018 · Cited by 46
Does Vascular Burden Contribute to the Progression of Mild Cognitive Impairment to Dementia?
Clerici, F., Caracciolo, B., Cova, I., Imperatori, S. F., Maggiore, L., Galimberti, D., Scarpini, E. A., Mariani, C. B., & Fratiglioni, L. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000343776 · Cited by 45
Tarraf, W., Kaplan, R. C., Daviglus, M. L., Gallo, L. C., Schneiderman, N., Penedo, F. J., Perreira, K. M., Lamar, M., Chai, A., Vásquez, P. M., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190830 · Cited by 46
Type 2 Diabetes and Ethnic Disparities in Cognitive Impairment
Noble, J. M., Manly, J. J., Schupf, N., Tang, M., & Luchsinger, J. A. (2012) · PubMed · doi:10.13016/gt2j-7why · Cited by 45
Self-citationShea, S., Lima, J. A. C., Roux, A. V. D., Jorgensen, N. W., & McClelland, R. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165651 · Cited by 51
Hussin, N. M., Shahar, S., Yahya, H. M., Din, N. C., Singh, D. K. A., & Omar, M. A. (2019) · BMC Public Health · doi:10.1186/s12889-019-7508-4 · Cited by 43
Paul, S. C., Saha, D., & Binukumar, B. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02365-2 · Cited by 43
Machida, T., Takata, F., Matsumoto, J., Miyamura, T., Hirata, R., Kimura, I., Kataoka, Y., Dohgu, S., & Yamauchi, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177447 · Cited by 43
Griffith, C. M., Macklin, L. N., Cai, Y., Sharp, A. A., Yan, X., Reagan, L. P., Strader, A. D., Rose, G. M., & Patrylo, P. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180707 · Cited by 44
Xia, W., Zhang, B., Yang, Y., Wang, P., Yang, Y., & Wang, S. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0046-x · Cited by 41
Guerrero‐Berroa, E., Ravona‐Springer, R., Schmeidler, J., Silverman, J. M., Sano, M. C., Koifman, K., Preiss, R., Hoffman, H., Heymann, A. D., & Beeri, M. S. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4008 · Cited by 42
Zhang, L., Ma, Q., & Zhou, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00201 · Cited by 45
Zhou, Y., Fang, R., Liu, L., Chen, S., & Tang, H. (2015) · Aging and Disease · doi:10.14336/ad.2014.1004 · Cited by 40
Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans
Unverzagt, F. W., Gao, S., Lane, K. A., Callahan, C. M., Ogunniyi, A. O., Baiyewu, O., Gureje, O., Hall, K. S., & Hendrie, H. C. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988707308804 · Cited by 40
Midlife Cardiovascular Risk Impacts Executive Function
Nishtala, A., Preis, S. R., Beiser, A., Devine, S., Hankee, L. D., Seshadri, S. S., Wolf, P. A., & Au, R. (2013) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182a715bc · Cited by 46
Duara, R., Barker, W., Loewenstein, D., & Bain, L. J. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.10.006 · Cited by 39
Effect of age and glucoregulation on cognitive performance
Messier, C., Tsiakas, M., Gagnon, M., & Desrochers, A. (2010) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903540323 · Cited by 39
Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
Milisav, I., Šuput, D., & Ribarič, S. (2015) · Molecules · doi:10.3390/molecules201219865 · Cited by 42
Metadata
- Authors
- Luchsinger, J. A., Reitz, C., Patel, B., Tang, M.-X., Manly, J. J., & Mayeux, R.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2007-04-01
- Volume
- 64
- Issue
- 4
- Pages
- 570
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2034664059
- Cited by
- 592
- References
- 58
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 24 · 2023: 26 · 2022: 24 · 2021: 28 · 2020: 37 · 2019: 32 · 2018: 28 · 2017: 29 · 2016: 35 · 2015: 33 · 2014: 47 · 2013: 34 · 2012: 39
- FWCI
- 19.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG007232, K08AG020856, AG 07702, AG 07232, 1K08 AG 20856-01)
- National Center for Research Resources (RR 00645, M01RR000645)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- type 2 diabetes, mild cognitive impairment, amnestic mild cognitive impairment, non-amnestic mild cognitive impairment, Alzheimer's disease risk, racial and ethnic disparities, African Americans, Hispanic Americans, minority groups, vascular risk factors, socioeconomic factors
- MeSH terms
- Aged, Aged, 80 and over, Analysis of Variance, Apolipoproteins E, Black or African American, Cognition Disorders, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Genotype, Hispanic or Latino, Humans, Male, Middle Aged, Neuropsychological Tests, New York, Risk Factors, Cohort Studies, Prevalence, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
